AI Summary
StalkPRKS remains in a Stage 2 advance with clear higher highs and higher lows, anchoring a bullish medium-term outlook. However, price is extended above rising EMAs at a key resistance level and overbought conditions with elevated Options Score suggest near-term stress. The Free Cash Flow + Buybacks strategy favors patient entries and stability, so waiting for a shallow pullback into the 9/21/50 EMA zone before initiating exposure is warranted.